Sigachi Industries logo

Sigachi Industries share price

NSE: SIGACHIBSE: 543389Pharmaceuticals & BiotechnologySmall Cap

Sigachi Industries Limited · Face value ₹1 · Listed Nov 2021 · Issue price ₹163
Last close ₹26.16up ₹1.33 (5.36%)BSE ₹26.16

Share price at the NSE close on 27 Oct 2026. Previous close ₹24.83.

27 Oct: open ₹24.97, high ₹26.28, low ₹24.88

52-week range of traded prices to 27 Oct 2026
₹16.65Low, 30 Mar 2026₹40.80High, 1 Dec 2025
Market cap
₹1,000 Cr1,573rd largest listed
P/E
39.42
P/E without one-offs
44.31
P/B
1.92
Dividend yield
0.38%
ROE
4.5%
ROE without one-offs
4.0%
ROCE
4.3%
Debt to equity
0.26
Volume, NSE
12,96,62029.1% delivered

Sigachi Industries share price chart

Daily closes since Nov 2021, adjusted for splits and bonuses

−31.2%over a year · Nifty 500 −8.8%

Results20-session average 16,95,304 shares a day, 44.0% delivered

Results

Consolidated; ₹ crore.Sigachi Industries quarterly results

Revenue growth, 12 months
−9.6%
Net profit growth, 12 months
–

Quarter to Jun 2026, against the quarter before

Revenue
₹121 Crdown 0.51%
Net profit
₹8.14 Crup 6.49%
Net margin
6.7%

Revenue by quarter

₹125 CrSep 24₹139 CrDec 24₹128 CrMar 25₹128 CrJun 25₹110 CrSep 25₹117 CrDec 25₹122 CrMar 26₹121 CrJun 26
Peak revenue ₹139 Cr, quarter to Dec 2024; lowest ₹110 Cr, quarter to Sep 2025

Net profit by quarter, a loss in red

  • Net profit
  • Loss
₹21 CrSep 24₹21 CrDec 24₹16 CrMar 25−₹101 CrJun 25₹11 CrSep 25−₹0.02 CrDec 25₹7.65 CrMar 26₹8.14 CrJun 26
A loss in 2 of the 8 quarters shown
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue125139128128110117122121
Net profit212116−10111088
Net margin16.8%14.7%12.6%−78.7%9.5%0.0%6.3%6.7%
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.

Business segments

In the year to Mar 2026 the company reports one business segment, Pharmaceuticals, which carries all its revenue. From the quarter to Jun 2026 it reports 2 businesses, by share of revenue: Pharmaceuticals, 89.2% and Operational and Management, 10.8%.

Valuation

Today, against the company's own history.Sigachi Industries PE ratio and valuation

Price to book

At or below today's level on 15% of 906 trading days since May 2022.

LowestHighest
Its median3.29Industry median2.99
Dividend yield

At or below today's level on 79% of 1,148 trading days since Jan 2022.

LowestHighest
Its median0.26%Industry median0.50%

Where the return came from

Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.

OverReturn a yearEarnings growthChange in P/EDividend yield
1 year−51.3%––0.6%
3 years−8.5%––0.4%
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 1 year is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.

Shareholding

Per cent of the company's shares, from the filing for Sep 2026.Sigachi Industries shareholding pattern

Shareholding by group

  • Promoters36.69%
  • Foreign institutions0.52%
  • Indian institutions0.05%
  • Individuals and others62.74%
Holder
RPS INDUSTRIES PRIVATE LIMITEDPromoter15.02%
CHIDAMBARNATHAN SHANMUGANATHANPromoter5.08%
RABINDRA PRASAD SINHAPromoter3.99%
AMIT RAJ SINHAPromoter3.66%
RAKESH YADAVResident individuals, over ₹2 lakh at face value2.65%
SWATI SINHAPromoter2.36%
Holders are named in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here and listed fund by fund below.

Promoters have pledged 20.04% of their shares. Since Jun 2026: promoters unchanged, foreign institutions −0.73 pts, Indian institutions +0.05 pts, mutual funds unchanged.

The filing reports 2,31,30,107 of its 38,21,17,010 shares locked in.

Mutual fund holdings

2 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 2 of the 2 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future.

Added
2
Fund
Motilal Oswal Mutual Fund logoMotilal Oswal BSE Healthcare ETFMotilal Oswal Mutual Fund6,7070.04%₹0.02 Cr
Bandhan Mutual Fund logoBandhan BSE Healthcare Index FundBandhan Mutual Fund3,1620.04%₹91,000
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.

Promoter and insider buying and selling

Trades made since 28 Oct 2025.Sigachi Industries insider trading

Bought on the market Sold on the market
  • Promoters and promoter group0 purchases, 1 saleNo purchase₹11 CrNet−₹11 Cr1 pledge created · 1 pledge invoked by a lender · 4 pledge filings of unclear kind · 2 off-market moves
  • Others: no market trade
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.

Sigachi Industries competitors and peers

Pharmaceuticals, 216 listed companies, priced on 27 Oct 2026. The table lists the 8 companies closest to Sigachi Industries in market cap.Healthcare companies

Where the company sits among the companies nearest its size

Return on equity across, P/E up, size is market cap
Company
Lincoln Pharmaceuticals logoLincoln PharmaceuticalsLINCOLN1,10211.421.45+10.2%+11.7%13.5%11.3%0.33%
Bafna Pharmaceuticals logoBafna PharmaceuticalsBAFNAPH1,047134.5210.89−3.1%−5.8%8.6%4.0%0.00%
Bajaj Healthcare logoBajaj HealthcareBAJAJHCARE1,04650.741.88+14.2%−55.0%4.0%10.2%0.48%
Remus Pharmaceuticals logoRemus PharmaceuticalsREMUS1,03828.052.96+37.6%–12.2%13.1%0.11%
Themis Medicare logoThemis MedicareTHEMISMED88222.062.21−12.8%–10.0%−10.5%0.52%
Shree Ganesh Remedies logoShree Ganesh RemediesSGRL85055.075.22−8.8%−29.4%10.0%10.6%0.00%
Aptus Pharma logoAptus PharmaAPPL810101.8528.49––31.7%–0.00%
Anuh Pharma logoAnuh PharmaANUHPHR79317.962.25+9.7%−4.3%13.0%15.2%1.90%
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.

Dividends

Per share, by the year it was paid for, and the latest payments.Sigachi Industries dividend history

Dividend per share, ₹, restated for later splits and bonuses

Mar 220.2Mar 230.1Mar 240.1Mar 250.1Mar 26
Highest ₹0.20 a share, year to Mar 2023.
Ex-dateTypePer share
22 Sep 2026Final₹0.10
16 Sep 2025Final₹0.10
28 Aug 2024Final₹0.10
31 Aug 2023Final₹1.00
2 Aug 2022Interim₹1.00
Latest payments, as declared, by ex-date.

Latest announcements

Routine notices left out.Sigachi Industries announcements

Sigachi Industries share price by year

Each calendar year to 2025.Sigachi Industries share price history

YearClose at year endChangeHighest closeLowest close
202531.12−37.7%58.8930.67
202449.94−2.8%91.5043.69
202351.40+89.5%55.9522.18
202227.12−32.0%39.7223.58
202139.89–62.8439.41
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2021 is from its first session, 15 Nov 2021.

Recent sessions

The 9 trading days to 26 Oct 2026, as traded on NSE; the latest is at the top of the page.

DateOpenHighLowCloseAverage priceVolumeDelivery
26 Oct 202625.5225.5224.7024.8324.957,00,81043.7%
23 Oct 202626.1026.1124.7725.1125.1511,79,37250.3%
22 Oct 202626.1026.5325.7725.9526.1310,42,32638.2%
21 Oct 202626.7126.8725.9226.1226.2116,45,13158.0%
19 Oct 202627.5227.8426.5826.7126.9210,15,15159.7%
16 Oct 202627.6827.8526.5027.5227.397,86,60349.1%
15 Oct 202628.2328.2527.6027.6927.8711,18,96955.8%
14 Oct 202628.2928.5127.7028.2428.1413,81,95550.6%
13 Oct 202628.4628.4727.8528.2728.0912,40,88659.3%
Prices in ₹ per share as traded, not adjusted.

Price adjustments

What the price chart is corrected for, so it reads as one share held throughout.Stock split history

Ex-dateEventPrice factorWhat happened
9 Oct 2023Split0.1000Each share became 10.
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.

Company details

Chairperson and managing director and CEO
Amit Raj Sinha
At the end of the quarter to Sep 2026
NSE symbol
SIGACHI
BSE code
543389
ISIN
INE0D0K01022
Industry
Pharmaceuticals & Biotechnology
CIN
L24110TG1989PLC009497
Corporate identity number, the registrar of companies' code for it
Incorporated
1989
Registered office
229/1 & 90, Kalyan's Tulsiram Chambers, Madinaguda, Hyderabad 500049, Telangana
Share registrar
Bigshare Services Pvt. Ltd
Keeps the register of shareholders and handles transfers and dividend payments